Surface Ophthalmics Previews Important Clinical Progress in 2021

PLEASANTON, Calif., Jan. 7, 2021 /PRNewswire/ — Surface Ophthalmics, Inc., a pharmaceutical company focused on development and commercialization of innovative therapeutics for ocular diseases, is pre …
(Orginal – Story lesen…)